School of Medicine

Researchers at the School of Medicine have found that the same mutation that gives tuberculosis bacteria drug resistance also elicits a weaker immune response. The findings are published in Nature Microbiology.

The Program in Physical Therapy at Washington University School of Medicine in St. Louis has a new clinical practice location in O’Fallon, Mo. The office will hold an open house Oct. 4. 

Mary Shelley’s “Frankenstein” is a thrilling adventure but also a prescient guidebook to the moral and ethical dilemmas of 20th and 21st century medicine. On Sept. 28-30, Washington University in St. Louis’ School of Medicine and College of Arts & Sciences will present a three-day forum exploring Shelley’s novel through the lens of contemporary medical practice.

A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at the School of Medicine.

The School of Medicine’s Jeffrey I. Gordon, MD, has received a 2018 Luminary Award from the Precision Medicine World Conference. He is being honored for his pioneering work in founding the field of gut microbiome research and for fundamentally altering the understanding of the origins of human health and disease, especially as they relate to nutrition.

The Office of Diversity Programs at the School of Medicine, in partnership with LGBTQ Med and OUTmed, is sponsoring a new program for LGBTQ+ (lesbian, gay, bisexual, transgender, queer+) identified medical students called OUTmentor.

Pamela K. Woodard, MD, professor of radiology at Washington University School of Medicine in St. Louis and the university’s Mallinckrodt Institute of Radiology, has been appointed to the Board of Chancellors of the American College of Radiology.

A new study from the School of Medicine shows that — in human tumor cells grown in the lab — a natural plant compound shuts down uveal melanoma cell growth.

A new study by the School of Medicine and others identifies mutations associated with relapse in ER positive breast cancer — knowledge that could lead to better therapies.

An experimental drug reduces brain atrophy in people with progressive multiple sclerosis, raising hopes that it also can reduce disability. The School of Medicine is one of 28 clinical sites participating in the study.